Patent law is marked by steady flow of transitions and changes, and this year is no exception. Important trends involving standard essential patents, trade secret disputes, and pharmaceuticals and biosimilars are reshaping litigation and the procurement of IP rights. These trends affect all venues for US IP litigation and patent prosecution, including the US Court of Appeals for the Federal Circuit, the US District Courts, the Patent Trial and Appeal Board (PTAB), and the US Patent and Trademark Office (USPTO).
At the USPTO, Director Iancu has stepped down, and while we await his replacement and look for policy shifts, especially involving patent eligible subject matter and the PTAB, any evolution at the USPTO will of course extend beyond the patent office, and affect IP licensing and enforcement. And in federal district court, Texas is home to the most active venue for patent litigation, but it is now the Western District, and this is largely due to the courtroom practices adopted by one judge.
Our panel of White & Case patent attorneys will discuss these recent events and trends, and their effects on patent practice. We expect the changes will have a profound impact on strategies for prosecution, litigation, portfolio development, and IP valuation.
Peter J. Armenio
Michael J. Songer
Dr. David Albagli
TIME AND DATE
Friday, October 15, 2021
9:00 a.m. – 10:30 a.m. JST
This publication is provided for your convenience and does not constitute legal advice. This publication is protected by copyright.
© 2021 White & Case LLP